Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats

By Hisatomi K.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4337-4339

Elsevier

Access to resources Recommend Favorite

Oral Delivery of Low Molecular Weight Heparin in Rat Cardiac Allografts

By Teranishi K.   Poston R.S.   Reitz B.A.   Robbins R.C.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 996-997

Elsevier

Access to resources Recommend Favorite

Threat matrix: Low-molecular-weight hyaluronan (HA) as a danger signal

By Powell Jonathan   Horton Maureen  

Immunologic Research, Vol. 31, Iss. 3, 2005-04 ,pp. : 207-218

Humana Press, Inc

Access to resources Recommend Favorite

Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry

By Bruscas Ma.   Nieto José   Perez-Pinar Monserrat   López-Jiménez Luciano   Fernández-Capitán Carmen   López-Chuliá Francisca   Orue-Lecue Ma.  

Annals of Hematology, Vol. 86, Iss. 7, 2007-07 ,pp. : 519-526

Springer Publishing Company

Access to resources Recommend Favorite

Effect of low molecular weight heparin on graft vascular disease in the rat cardiac allograft model

By Teranishi K.   Poston R.S.   Reitz B.A.   Robbins R.C.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 103-105

Elsevier

Access to resources Recommend Favorite